List downloaded from Dataset DOI:10.5281/zenodo.4587355 A - Alimentary tract and metabolism A01 - Stomatological preparations A01A - Stomatological preparations A01AC - Corticosteroids for local oral treatment A01AC03 - Hydrocortisone A - Alimentary tract and metabolism A07 - Antidiarrheals, intestinal antiinflammatory/antiinfective agents A07E - Intestinal antiinflammatory agents A07EA - Corticosteroids acting locally A07EA02 - Hydrocortisone C - Cardiovascular system C05 - Vasoprotectives C05A - Agents for treatment of hemorrhoids and anal fissures for topical use C05AA - Corticosteroids C05AA01 - Hydrocortisone D - Dermatologicals D07 - Corticosteroids, dermatological preparations D07A - Corticosteroids, plain D07AA - Corticosteroids, weak (group i) D07AA02 - Hydrocortisone D - Dermatologicals D07 - Corticosteroids, dermatological preparations D07X - Corticosteroids, other combinations D07XA - Corticosteroids, weak, other combinations D07XA01 - Hydrocortisone H - Systemic hormonal preparations, excl

In essence, there's no difference in terms of the core substance
The most important difference lies not only in the active ingredient, but above all in the approval and treatment goal
However, a long-term exploratory RCT in 150 people with obesity found that differences in eating disorders psychopathology scores were not maintained at 52 weeks when liraglutide in combination with behavioral therapy was compared with behavioral therapy alone 215
They are often prescribed to patients with obesity and/or Type 2 diabetes
This dietary supplement only uses natural ingredients and does not contain any synthetic preservatives, chemicals, or additives